RxDoctor Payments Data

Mohamed Djelmami Hani, MD

Clinical Cardiac Electrophysiology · Milwaukee, WINPI 1912955766

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $10,765 of the $16,337 with a category attached, or 65.9%. 7 manufacturers reported payments, led by Boston Scientific at 47.9% of the total. Reporting peaked in 2024 at $7,764 and has fallen 54.0% since, to $3,568 in 2025.

$16,337in general payments, 2019–2025

Across 94 payments — averaging $173.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$8K
  • Medtronic$4K
  • Altathera Pharmaceuticals LLC$2K
  • Abbott$1K
  • Philips North America LLC$1K
  • Cardiofocus, Inc.$101
  • plus $41 from 1 others
$125,444in research payments, 2019–2025

Across 53 payments — averaging $2366.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$73K
  • Medtronic$30K
  • Abbott$23K

What the payments were for

  • Consulting fees$1,87511%
  • Travel & lodging$10,76566%
  • Food & beverage$3,61922%
  • Education$780%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,337 in reported general payments places this provider in the 60th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.

See all clinical cardiac electrophysiology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$285,221
Medicare patients
854
Services billed
3,691

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban1,456$1,561,575
XareltoRivaroxaban376$386,975
MultaqDronedarone Hcl21$28,185
Flecainide Acetate717$25,016
Dofetilide135$10,734
Mexiletine Hcl78$10,718
Metoprolol Succinate801$9,368
Amiodarone Hcl474$8,120
Propafenone Hcl ErPropafenone Hcl32$5,165
Diltiazem 24hr Er (Cd)Diltiazem Hcl224$5,064
Midodrine Hcl50$3,749
Propafenone Hcl61$3,592
Metoprolol Tartrate582$3,063
Digoxin131$2,854
Warfarin Sodium283$2,653

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →